509 related articles for article (PubMed ID: 31316723)
41. Higher expression of miR-150-5p promotes tumorigenesis by suppressing LKB1 in non-small cell lung cancer.
Wu Z; Li W; Li J; Zhang Y; Zhang X; Xu Y; Hu Y; Li Q; Sun Q; Ma Z
Pathol Res Pract; 2020 Nov; 216(11):153145. PubMed ID: 32827803
[TBL] [Abstract][Full Text] [Related]
42. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
Xiao XH; He SY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3130-3142. PubMed ID: 32271431
[TBL] [Abstract][Full Text] [Related]
43. miR-106a promotes growth and metastasis of non-small cell lung cancer by targeting PTEN.
Xie X; Liu HT; Mei J; Ding FB; Xiao HB; Hu FQ; Hu R; Wang MS
Int J Clin Exp Pathol; 2015; 8(4):3827-34. PubMed ID: 26097565
[TBL] [Abstract][Full Text] [Related]
44. LINC00689 participates in proliferation, chemoresistance and metastasis via miR-31-5p/YAP/β-catenin axis in colorectal cancer.
Du YL; Liang Y; Shi GQ; Cao Y; Qiu J; Yuan L; Yong Z; Liu L; Li J
Exp Cell Res; 2020 Oct; 395(1):112176. PubMed ID: 32682784
[TBL] [Abstract][Full Text] [Related]
45. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
Tang Y; Xiao G; Chen Y; Deng Y
Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
[TBL] [Abstract][Full Text] [Related]
46. Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis.
Jin D; Guo J; Wu Y; Chen W; Du J; Yang L; Wang X; Gong K; Dai J; Miao S; Li X; Su G
J Exp Clin Cancer Res; 2020 Jan; 39(1):6. PubMed ID: 31906986
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of ERK1/2 down-regulates the Hippo/YAP signaling pathway in human NSCLC cells.
You B; Yang YL; Xu Z; Dai Y; Liu S; Mao JH; Tetsu O; Li H; Jablons DM; You L
Oncotarget; 2015 Feb; 6(6):4357-68. PubMed ID: 25738359
[TBL] [Abstract][Full Text] [Related]
48. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer.
Baumgartner U; Berger F; Hashemi Gheinani A; Burgener SS; Monastyrskaya K; Vassella E
Mol Cancer; 2018 Feb; 17(1):44. PubMed ID: 29455644
[TBL] [Abstract][Full Text] [Related]
49. XB130, regulated by miR-203, miR-219, and miR-4782-3p, mediates the proliferation and metastasis of non-small-cell lung cancer cells.
Wang Q; Yang G; Jiang Y; Luo M; Li C; Zhao Y; Xie Y; Song K; Zhou J
Mol Carcinog; 2020 May; 59(5):557-568. PubMed ID: 32159887
[TBL] [Abstract][Full Text] [Related]
50. MicroRNA-137 inhibits cell migration and invasion by targeting bone morphogenetic protein-7 (BMP7) in non-small cell lung cancer cells.
Yang YR; Li YX; Gao XY; Zhao SS; Zang SZ; Zhang ZQ
Int J Clin Exp Pathol; 2015; 8(9):10847-53. PubMed ID: 26617798
[TBL] [Abstract][Full Text] [Related]
51. The Sp1/FOXC1/HOTTIP/LATS2/YAP/β-catenin cascade promotes malignant and metastatic progression of osteosarcoma.
Liu K; Ni JD; Li WZ; Pan BQ; Yang YT; Xia Q; Huang J
Mol Oncol; 2020 Oct; 14(10):2678-2695. PubMed ID: 32634265
[TBL] [Abstract][Full Text] [Related]
52. Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/β-catenin signaling pathway.
Qi G; Li L
Biomed Pharmacother; 2020 Jun; 126():110100. PubMed ID: 32197208
[TBL] [Abstract][Full Text] [Related]
53. WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway.
Hum M; Tan HJ; Yang Y; Srivastava S; Teh M; Lim YP
FASEB J; 2021 Feb; 35(2):e21290. PubMed ID: 33475198
[TBL] [Abstract][Full Text] [Related]
54. miR-212-5p exerts tumor promoter function by regulating the Id3/PI3K/Akt axis in lung adenocarcinoma cells.
Chen FF; Sun N; Wang Y; Xi HY; Yang Y; Yu BZ; Li XJ
J Cell Physiol; 2020 Oct; 235(10):7273-7282. PubMed ID: 32039486
[TBL] [Abstract][Full Text] [Related]
55. MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.
Li J; Wang Q; Wen R; Liang J; Zhong X; Yang W; Su D; Tang J
J Cell Mol Med; 2015 Dec; 19(12):2793-805. PubMed ID: 26283050
[TBL] [Abstract][Full Text] [Related]
56. miR-605-5p promotes invasion and proliferation by targeting TNFAIP3 in non-small-cell lung cancer.
Liao Y; Cao L; Wang F; Pang R
J Cell Biochem; 2020 Jan; 121(1):779-787. PubMed ID: 31452243
[TBL] [Abstract][Full Text] [Related]
57. Salidroside suppresses nonsmall cell lung cancer cells proliferation and migration via microRNA-103-3p/Mzb1.
Zhu X; Liu D; Wang Y; Dong M
Anticancer Drugs; 2020 Aug; 31(7):663-671. PubMed ID: 32304408
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA-616 promotes the growth and metastasis of non-small cell lung cancer by targeting SOX7.
Wang D; Cao Q; Qu M; Xiao Z; Zhang M; Di S
Oncol Rep; 2017 Oct; 38(4):2078-2086. PubMed ID: 28765960
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-7 inhibits cell proliferation, migration and invasion in human non-small cell lung cancer cells by targeting FAK through ERK/MAPK signaling pathway.
Cao Q; Mao ZD; Shi YJ; Chen Y; Sun Y; Zhang Q; Song L; Peng LP
Oncotarget; 2016 Nov; 7(47):77468-77481. PubMed ID: 27764812
[TBL] [Abstract][Full Text] [Related]
60. MiR-760 suppresses non-small cell lung cancer proliferation and metastasis by targeting ROS1.
Yan C; Zhang W; Shi X; Zheng J; Jin X; Huo J
Environ Sci Pollut Res Int; 2018 Jul; 25(19):18385-18391. PubMed ID: 29372517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]